Pfizer Update on COVID-19 Vaccine Distribution
The Facts About Pfizer and BioNTech’s COVID-19 Vaccine
COVID-19 SCIENTIFIC RESOURCES
The Colleague & Dad Who Keeps Our Medicines and Vaccines on Ice
Find a Trial
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
THE ANTIGEN: #COVID19 PODCAST
VISIT OUR COVID-19 HUB
Latest News
XALKORI is the first biomarker-driven therapy for relapsed or refractory ALCL in young people Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for XALKORI ® (crizotinib) for the treatment of pediatric patients 1 year of age and older and young adults with relapsed or refractory, systemic anaplastic large cell lymphoma (ALCL) that is anaplastic lymphoma kinase (ALK)-positive. The safety and efficacy of…